/https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/62bce635c9907ca3b4e42ca0fc2f88c0.jpg)
ehealth radio network
eHealth Radio Network
The Future of Peptide Medicine: Separating Science from Hype
OCT 17, 202611 MIN
/https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/235b2482f7b7a92435c3c6481905f6ae.jpg)
Description
Karthik Achari, Founder and Clinician at PepMD, a healthcare company advancing the safe and responsible use of peptide medicine through physician education, credentialing, and personalized patient care joins eHealth Radio and the Health News Channel. Listen to interview with host Eric Michaels & guest Karthik Achari discuss the following: Peptide medicine has become one of the fastest-growing areas in healthcare. What is driving this surge in interest, and what should patients understand before exploring peptide therapies?
There's a lot of misinformation surrounding GLP-1 medications and peptides online. How can patients distinguish credible medical guidance from marketing hype?
You've been a strong advocate for physician education and credentialing in peptide medicine. Why is provider training so important, and how does it improve patient outcomes?
As FDA regulations continue to evolve, how do you see the future of peptide medicine changing over the next few years?
For healthcare professionals who want to responsibly incorporate peptide therapies into their practice, what are the first steps they should take?
Karthik Achari is a Clinician and Founder of PepMD, a private standards body developing the credentialing and trust infrastructure for peptide medicine, and the first to bring clinician credentialing, pharmacy recognition, and research site authorization under a single unified standard: The Standard for Peptide Medicine. A clinician by training, Achari attended Bradley University’s Doctor of Nursing Practice / Family Nurse Practitioner program and built his perspective on healthcare by working with providers across the peptide space and by operating healthcare businesses. This dual experience has given him a comprehensive understanding of how the system functions in practice, where standards exist, where they fall short, and where critical gaps remain. In 2026, Achari founded PepMD to address the rapid growth of peptide medicine without the infrastructure needed to support it. Modeled in part after established bodies like The Joint Commission and PCAB, PepMD credentials clinicians, recognizes pharmacies, and authorizes research sites under one standard. His work focuses on bringing structure, credibility, and oversight to an evolving sector that has outpaced traditional regulatory frameworks. Website: pepmd.com Linkedin: linkedin.com/company/pepmd Instagram: instagram.com/pepmd People also listened to this: Beating Bipolar Disorder with Stella Furlong

